Status: current, Defined. Date: 31-Jul 2023. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4830891000168113 | Xeljanz XR (tofacitinib 11 mg) modified release tablet, 30 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4830901000168112 | Xeljanz XR 11 mg modified release tablet, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Xeljanz XR 11 mg modified release tablet, 30 | Is a | tofacitinib 11 mg modified release tablet, 30 | true | Inferred relationship | Some | ||
Xeljanz XR 11 mg modified release tablet, 30 | Is a | trade product pack | true | Inferred relationship | Some | ||
Xeljanz XR 11 mg modified release tablet, 30 | has TP | Xeljanz XR | true | Inferred relationship | Some | ||
Xeljanz XR 11 mg modified release tablet, 30 | has TPUU | Xeljanz XR 11 mg modified release tablet | true | Inferred relationship | Some | 2091188098 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Xeljanz XR 11 mg modified release tablet, 30, bottle | Is a | True | Xeljanz XR 11 mg modified release tablet, 30 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set